IONS CIK: 874015

Ionis Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
2.35
FY22:
2.20
FY23:
2.64
FY24:
2.62
FY25:
2.99
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.27
FY22:
0.33
FY23:
0.35
FY24:
0.38
FY25:
0.53
Total assets
Change from FY21 to FY25
billions USD
FY21:
2.61
FY22:
2.53
FY23:
2.99
FY24:
3.00
FY25:
3.52

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.24
FY22:
0.31
FY23:
0.45
FY24:
0.31
FY25:
0.78
(negative)
Change from FY21 to FY25
billions USD
FY21:
1.60
FY22:
1.65
FY23:
2.16
FY24:
2.11
FY25:
2.25
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.77
FY22:
0.57
FY23:
0.39
FY24:
0.59
FY25:
0.49
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
2.61
FY22:
2.53
FY23:
2.99
FY24:
3.00
FY25:
3.52

All amounts in billions USD Data source:SEC EDGAR